These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 21872827

  • 1. Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas.
    Jarmalaite S, Laurinaviciene A, Tverkuviene J, Kalinauskaite N, Petroska D, Böhling T, Husgafvel-Pursiainen K.
    Cancer Genet; 2011 Jul; 204(7):398-404. PubMed ID: 21872827
    [Abstract] [Full Text] [Related]

  • 2. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
    Valleley EM, Cordery SF, Bonthron DT.
    Hum Mol Genet; 2007 Apr 15; 16(8):972-81. PubMed ID: 17341487
    [Abstract] [Full Text] [Related]

  • 3. Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.
    Lemeta S, Jarmalaite S, Pylkkänen L, Böhling T, Husgafvel-Pursiainen K.
    J Neuropathol Exp Neurol; 2007 Sep 15; 66(9):860-7. PubMed ID: 17805016
    [Abstract] [Full Text] [Related]

  • 4. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM, Cordery SF, Carr IM, MacLennan KA, Bonthron DT.
    Genes Chromosomes Cancer; 2010 May 15; 49(5):480-6. PubMed ID: 20175198
    [Abstract] [Full Text] [Related]

  • 5. Frequent loss of heterozygosity at 6q in pheochromocytoma.
    Lemeta S, Salmenkivi K, Pylkkänen L, Sainio M, Saarikoski ST, Arola J, Heikkilä P, Haglund C, Husgafvel-Pursiainen K, Böhling T.
    Hum Pathol; 2006 Jun 15; 37(6):749-54. PubMed ID: 16733217
    [Abstract] [Full Text] [Related]

  • 6. Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
    Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C, Bockaert J, Theillet C, Spengler D, Journot L.
    Oncogene; 1999 Jul 08; 18(27):3979-88. PubMed ID: 10435621
    [Abstract] [Full Text] [Related]

  • 7. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
    Bilanges B, Varrault A, Mazumdar A, Pantaloni C, Hoffmann A, Bockaert J, Spengler D, Journot L.
    Oncogene; 2001 Mar 08; 20(10):1246-53. PubMed ID: 11313869
    [Abstract] [Full Text] [Related]

  • 8. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
    Kamikihara T, Arima T, Kato K, Matsuda T, Kato H, Douchi T, Nagata Y, Nakao M, Wake N.
    Int J Cancer; 2005 Jul 10; 115(5):690-700. PubMed ID: 15751035
    [Abstract] [Full Text] [Related]

  • 9. Methylation status of imprinted genes DLK1-GTL2, MEST (PEG1), ZAC (PLAGL1), and LINE-1 elements in spermatozoa of normozoospermic men, unlike H19 imprinting control regions, is not associated with idiopathic recurrent spontaneous miscarriages.
    Ankolkar M, Salvi V, Warke H, Vundinti BR, Balasinor NH.
    Fertil Steril; 2013 May 10; 99(6):1668-73. PubMed ID: 23415968
    [Abstract] [Full Text] [Related]

  • 10. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
    Basyuk E, Coulon V, Le Digarcher A, Coisy-Quivy M, Moles JP, Gandarillas A, Journot L.
    Mol Cancer Res; 2005 Sep 10; 3(9):483-92. PubMed ID: 16179495
    [Abstract] [Full Text] [Related]

  • 11. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S, Hauses M, Appelt H, Friedrich K, Schackert HK, Eckelt U.
    Head Neck; 2004 Apr 10; 26(4):338-44. PubMed ID: 15054737
    [Abstract] [Full Text] [Related]

  • 12. The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
    Pagotto U, Arzberger T, Theodoropoulou M, Grübler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK, Spengler D.
    Cancer Res; 2000 Dec 15; 60(24):6794-9. PubMed ID: 11156367
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation.
    Barz T, Hoffmann A, Panhuysen M, Spengler D.
    Cancer Res; 2006 Dec 15; 66(24):11975-82. PubMed ID: 17178896
    [Abstract] [Full Text] [Related]

  • 14. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
    Arima T, Yamasaki K, John RM, Kato K, Sakumi K, Nakabeppu Y, Wake N, Kono T.
    Genomics; 2006 Nov 15; 88(5):650-8. PubMed ID: 16928428
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.
    Mircescu H, Wilkin F, Paquette J, Oligny LL, Decaluwe H, Gaboury L, Nolet S, Van Vliet G, Deal C.
    J Pediatr; 2001 Feb 15; 138(2):269-73. PubMed ID: 11174629
    [Abstract] [Full Text] [Related]

  • 16. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma.
    Rutherford S, Yu Y, Rumpel CA, Frierson HF, Moskaluk CA.
    Cancer Lett; 2006 May 18; 236(2):309-17. PubMed ID: 16054751
    [Abstract] [Full Text] [Related]

  • 17. Frequent promoter methylation of tumor-related genes in sporadic and men2-associated pheochromocytomas.
    Dammann R, Schagdarsurengin U, Seidel C, Trümpler C, Hoang-Vu C, Gimm O, Dralle H, Pfeifer GP, Brauckhoff M.
    Exp Clin Endocrinol Diabetes; 2005 Jan 18; 113(1):1-7. PubMed ID: 15662588
    [Abstract] [Full Text] [Related]

  • 18. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus.
    Mackay DJ, Coupe AM, Shield JP, Storr JN, Temple IK, Robinson DO.
    Hum Genet; 2002 Feb 18; 110(2):139-44. PubMed ID: 11935319
    [Abstract] [Full Text] [Related]

  • 19. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
    Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayashizaki Y.
    Hum Mol Genet; 2000 Feb 12; 9(3):453-60. PubMed ID: 10655556
    [Abstract] [Full Text] [Related]

  • 20. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.
    Oncogene; 2001 Nov 08; 20(51):7573-7. PubMed ID: 11709729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.